-Float = 27M
-Nov 10 2020: Announces Bemarituzumab Plus Chemotherapy Demonstrates Significant Progression-Free and Overall Survival Benefit Compared to Placebo
-Nov 11 2020: Multiple PT upgrades
-SPY pattern: Consolidation
-Intraday pattern: Bear Flag
-Other notes: N/a
Strategy: Gap & Crap
Confluence: 1m-JL
Strike Zone: 19.5 - 21
Sizing (lots + emergency): 100 (wanted to get bigger at higher prices)
Risk (stop / Rs): Hold above 21
Wanted to get bigger at higher prices with a stop above 21. Started scaling out when I was 1 point ITM. Could have gotten 1 extra R had I held for longer. Cut my second try quickly when I found out news of PT upgrades. +1R
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-11-11 10:07:32 | FPRX | sell | $19.190 | short |
2020-11-11 10:13:19 | FPRX | sell | $19.440 | short |
2020-11-11 10:25:55 | FPRX | buy | $18.420 | short |
2020-11-11 10:26:36 | FPRX | buy | $17.980 | short |
2020-11-11 10:27:24 | FPRX | buy | $17.700 | short |
2020-11-11 10:27:53 | FPRX | buy | $17.580 | short |
2020-11-11 10:29:43 | FPRX | buy | $17.740 | 0 |
2020-11-11 11:06:57 | FPRX | sell | $19.550 | short |
2020-11-11 11:08:15 | FPRX | buy | $19.200 | 0 |
Thanks, could have been more patient with covers, as I was treating this as an ADF
Thanks. If you don't mind me asking, what broker do you use? I'd like to short some of these small caps that pop briefly in the morning and fade. Haven't made much of an effort to pursue shorting yet. From what I understand it can be difficult to find shares to short and the fees can be high to borrow shares.
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!
Outstanding shorts.